GERD Secondary to PTSD
Two pathways to service connection
Pathway one: PTSD and chronic anxiety drive sustained sympathetic-nervous-system activation, which is linked in the medical literature to delayed gastric emptying, lower esophageal sphincter dysfunction, and increased reflux frequency. A clinician's opinion connecting this physiology to the 's current GERD supports the under § 3.310(a).
Pathway two: medications commonly prescribed for PTSD (SSRIs such as sertraline, SNRIs, tricyclics, benzodiazepines) have documented GI side effects including reflux. Under § 3.310, a condition caused or aggravated by medication prescribed for a service-connected disability is itself service-connected.
Rating under DC 7206
VA amended 7206 effective May 2024, restructuring the criteria around objective endoscopic findings and functional impact rather than the old hiatal-hernia analogy. Current evaluations range from 10% (symptomatic but minimal functional impact) to 80% (severe reflux with documented complications such as Barrett's esophagus, stricture, or recurrent aspiration).
Always confirm current criteria at the eCFR; rating-schedule amendments are common in this area.
Evidence VA looks for
- Current diagnosis of GERD in VA, private, or military treatment records.
- in effect for PTSD or another mental-health condition.
- Medical opinion identifying the secondary pathway (autonomic or medication-induced).
- Endoscopy, esophageal manometry, or pH-monitoring results if available — these drive the 7206 percentage.
- Medication list documenting the PTSD pharmacotherapy implicated in the medication-induced theory.
Aggravation vs. causation
Even if GERD pre-existed the PTSD diagnosis or PTSD medication regimen, secondary is available on an theory under § 3.310(b) — the service-connected condition need only have permanently worsened the non-service-connected GERD beyond its natural progression. The medical opinion should explicitly address aggravation when causation is not the cleaner theory.
Where these claims break down
- ×Claiming GERD secondary to PTSD without identifying which pathway (autonomic vs. medication) the nexus opinion is using.
- ×Submitting only the medication list without an opinion tying medication to current GERD.
- ×Ignoring the 2024 DC 7206 rewrite and quoting outdated rating criteria.
- ×Letting an aggravation theory go unexplored when causation is harder to establish.
Frequently Asked Questions
Useful Tools & Topics
Have questions about your specific case?
Every veteran's facts are different. A free initial consultation with a VA-Accredited Claims Agent can tell you whether your matter is a fit for representation — and what the right next step looks like either way.
Disclaimer: This page is for educational purposes only and does not constitute legal advice. Oakridge Claims is a private business and is not affiliated with, endorsed by, or operated by the U.S. Department of Veterans Affairs. No guarantees of outcomes are made. Each claim is decided on its individual facts.
Related guides
Tinnitus Secondary to Hearing Loss
How VA evaluates tinnitus claimed as secondary to service-connected hearing loss under DC 6260 — and why the 10% schedular ceiling matters.
Erectile Dysfunction Secondary to PTSD or Medications
How VA evaluates erectile dysfunction as secondary to PTSD, depression, diabetes, or psychotropic medications — including SMC-K for loss of use.
Hypertension Secondary to Diabetes
How VA evaluates hypertension claimed as secondary to service-connected Type 2 diabetes mellitus, including the diabetic-nephropathy pathway.
Fibromyalgia Secondary to PTSD
How VA evaluates fibromyalgia claimed as secondary to service-connected PTSD — central-sensitization pathway, DC 5025 rating tiers, and Gulf War overlap.